Five individuals were indicted for an insider trading scheme, accused of using nonpublic information for over $600,000 in ...

Sun Pharma invests $25 million in Pharmazz Inc for drug candidates Sovateltide and Centhaquine, with potential licensing ...

The investment includes a mix of fresh equity and the conversion of a prior investment made through a Simple Agreement for ...

Geneva, Switzerland Saturday, May 24, 2025, 15:30 Hrs [IST] ...

From 2015 to 2021, there was a decrease in the incidence of dementia, but an increase in prevalence, according to a study ...

Sun Pharmaceutical Industries Ltd has agreed to a $25 million investment in US-based Pharmazz Inc. The move will raise Sun ...

Qamzova is a non-steroidal anti-inflammatory that provides 24-hour pain relief in a single shot, reducing post-surgery opioid ...

The awards are subject to the terms and conditions of the Inducement Plan and the terms and conditions of the RSU agreement covering the grant. The awards are being granted as an inducement material ...

Speakers: Andrew Oxtoby, Chief Executive Officer & Matthew Feinsod, Chief Medical Officer Date: Tuesday, May 27 th, 2025 Kalaris is a clinical-stage biopharmaceutical company dedicated to the ...